Santhera Pharmaceuticals Holding AG
F:S3F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
F:S3F
|
CH |
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
D
|
Deutsche Telekom AG
XHAM:DTE
|
DE |
Multiples-Based Value
The Multiples-Based Value for Santhera Pharmaceuticals Holding AG (S3F) under the Base Case is 13.16 EUR. Compared with the current market price of 13.64 EUR, the stock appears Overvalued by 4% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.